Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Aveanna Healthcare Holdings , Inc. (NASDAQ:AVAH), a healthcare company with a market capitalization of $1.17 billion, witnessed significant stock sales by a major shareholder, Robert M. Williams Jr., according to recent filings. Over two days, May 14 and 15, Williams sold shares worth approximately $606,940. The transactions were executed at prices ranging from $5.88 to $5.89 per share, close to the stock’s 52-week high of $6.19.
The sales were conducted through various entities associated with Williams, including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC. These transactions reduced Williams’ direct and indirect holdings in Aveanna Healthcare, which has seen remarkable performance with a 126% return over the past year. InvestingPro analysis reveals the stock is currently trading at Fair Value, with 11 additional exclusive insights available to subscribers.
The sales were part of a pre-established trading plan under Rule 10b5-1, which was adopted in December 2024. This rule allows insiders to set up a predetermined schedule for selling stocks, helping to avoid potential insider trading accusations.
Following these transactions, Williams continues to hold a substantial number of shares through indirect ownership, reflecting his ongoing interest in the company’s performance.
In other recent news, Aveanna Healthcare Holdings Inc. reported impressive financial results for the first quarter of 2025. The company achieved earnings per share of $0.10, surpassing the anticipated loss of $0.0014. Revenue for the quarter reached $559 million, significantly exceeding the forecast of $513.7 million. This strong performance reflects the company’s effective cost management and strategic growth initiatives. Additionally, Aveanna projects its 2025 revenue to exceed $2.15 billion, with an adjusted EBITDA projection of over $270 million.
In another development, Aveanna Healthcare announced the results of its 2025 Annual Meeting of Stockholders. The stockholders voted on several proposals, including the election of directors and the ratification of the company’s independent auditor, Ernst & Young LLP. All proposals were approved, indicating continued stockholder confidence in the company’s leadership.
Furthermore, Aveanna Healthcare is set to expand its operations through the acquisition of ThriveSkilled Pediatrics, which is expected to enhance the company’s preferred payer and government affairs strategies. This acquisition aligns with Aveanna’s goal of increasing its footprint in key states and strengthening its partnerships. These recent developments underscore Aveanna’s ongoing efforts to drive growth and improve financial performance in a challenging healthcare environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.